Get startedLog in
    Picture of Shanghai Fosun Pharmaceutical logo

    2196 — Shanghai Fosun Pharmaceutical News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    All News

    Brief: Shanghai Fosun Pharmaceutical Group's Unit Signs Licensing Deal With Amberstone

    Picture of Shanghai Fosun Pharmaceutical logoShanghai Fosun Pharmaceutical
    23/09/2026 09:41
    BRIEF-Shanghai Fosun Pharmaceutical Group's Unit Signs Licensing Deal With Amberstone
    Sept 23 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:
    • SAYS UNIT SIGNED LICENSING DEAL WITH AMBERSTONE FOR TCE PRODUCTS
    • SAYS UNIT TO PAY AMBERSTONE UP TO $236.16 MLN IN UPFRONT, R&D FEES, DEVELOPMENT AND REGULATORY MILESTONES
    Source text
    Further company coverage: 600196.SS

     (Reporting by Beijing Newsroom)
     ((Shi.Bu@thomsonreuters.com;))

    Recent news on Shanghai Fosun Pharmaceutical

    See all news